234 related articles for article (PubMed ID: 30447463)
21. Low insulin resistance after surgery predicts poor GH suppression one year after complete resection for acromegaly: a retrospective study.
Edo N; Morita K; Suzuki H; Takeshita A; Miyakawa M; Fukuhara N; Nishioka H; Yamada S; Takeuchi Y
Endocr J; 2016 May; 63(5):469-77. PubMed ID: 26949262
[TBL] [Abstract][Full Text] [Related]
22. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly.
Biermasz NR; van Dulken H; Roelfsema F
J Clin Endocrinol Metab; 2000 Dec; 85(12):4596-602. PubMed ID: 11134114
[TBL] [Abstract][Full Text] [Related]
23. Predictors for Remission after Transsphenoidal Surgery in Acromegaly: A Dutch Multicenter Study.
Coopmans EC; Postma MR; Wolters TLC; van Meyel SWF; Netea-Maier R; van Beek AP; Neggers SJCMM
J Clin Endocrinol Metab; 2021 May; 106(6):1783-1792. PubMed ID: 33544833
[TBL] [Abstract][Full Text] [Related]
24. Intraoperative magnetic resonance imaging-assisted transsphenoidal pituitary surgery in patients with acromegaly.
Bellut D; Hlavica M; Schmid C; Bernays RL
Neurosurg Focus; 2010 Oct; 29(4):E9. PubMed ID: 20887134
[TBL] [Abstract][Full Text] [Related]
25. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
Gondim JA; Almeida JP; de Albuquerque LA; Gomes E; Schops M; Ferraz T
Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132
[TBL] [Abstract][Full Text] [Related]
26. Results of endoscopic transsphenoidal pituitary surgery in 40 patients with a growth hormone-secreting macroadenoma.
Wagenmakers MA; Netea-Maier RT; van Lindert EJ; Pieters GF; Grotenhuis AJ; Hermus AR
Acta Neurochir (Wien); 2011 Jul; 153(7):1391-9. PubMed ID: 21347581
[TBL] [Abstract][Full Text] [Related]
27. Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission.
De P; Rees DA; Davies N; John R; Neal J; Mills RG; Vafidis J; Davies JS; Scanlon MF
J Clin Endocrinol Metab; 2003 Aug; 88(8):3567-72. PubMed ID: 12915637
[TBL] [Abstract][Full Text] [Related]
28. The common consensus criteria have high predictive values for long-term postoperative acromegaly remission.
Kristof RA; Grote A; Redel L; Neuloh G; Klingmüller D; Schramm J
Acta Neurochir (Wien); 2011 Jan; 153(1):19-25. PubMed ID: 20845050
[TBL] [Abstract][Full Text] [Related]
29. Outcome of surgical intrasellar growth hormone tumor performed by a pituitary specialist surgeon in a developing country.
Gondim JA; Ferraz T; Mota I; Studart D; Almeida JP; Gomes E; Schops M
Surg Neurol; 2009 Jul; 72(1):15-9; discussion 19. PubMed ID: 18440607
[TBL] [Abstract][Full Text] [Related]
30. Reliability of the oral glucose tolerance test in the early postoperative assessment of acromegaly remission.
Kristof RA; Neuloh G; Redel L; Klingmüller D; Schramm J
J Neurosurg; 2002 Dec; 97(6):1282-6. PubMed ID: 12507124
[TBL] [Abstract][Full Text] [Related]
31. Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients.
Shimon I; Cohen ZR; Ram Z; Hadani M
Neurosurgery; 2001 Jun; 48(6):1239-43; discussion 1244-5. PubMed ID: 11383725
[TBL] [Abstract][Full Text] [Related]
32. 2010 versus the 2000 consensus criteria in patients with normalised insulin-like growth factor 1 after transsphenoidal surgery has high predictive values for long-term recurrence-free survival in acromegaly.
Shen M; Chen Z; Shou X; He W; Qiao N; Ma Z; Ye Z; Zhang Y; Zhang Q; Zhou X; Cao X; Zhang Z; Ye H; Li Y; Zhao Y; Li S; He M; Wang Y
J Neuroendocrinol; 2021 May; 33(5):e12958. PubMed ID: 33998086
[TBL] [Abstract][Full Text] [Related]
33. Intraoperative Scoring System to Predict Postoperative Remission in Endoscopic Endonasal Transsphenoidal Surgery for Growth Hormone-Secreting Pituitary Adenomas.
Yano S; Shinojima N; Kawashima J; Kondo T; Hide T
World Neurosurg; 2017 Sep; 105():375-385. PubMed ID: 28602880
[TBL] [Abstract][Full Text] [Related]
34. Factors influencing the outcome of microsurgical transsphenoidal surgery for pituitary adenomas: a study on 184 patients.
Lampropoulos KI; Samonis G; Nomikos P
Hormones (Athens); 2013; 12(2):254-64. PubMed ID: 23933694
[TBL] [Abstract][Full Text] [Related]
35. A follow-up study on outcomes of endoscopic transsphenoidal approach for acromegaly.
Aydin S; Ozoner B; Sahin S; Alizada O; Comunoglu N; Oz B; Gazioglu N; Kadioglu P; Tanriover N
Clin Neurol Neurosurg; 2020 Nov; 198():106201. PubMed ID: 32927330
[TBL] [Abstract][Full Text] [Related]
36. Endoscopic Endonasal Approach to the Growth Hormone-Secreting Pituitary Adenomas: Endocrinologic Outcome in 68 Patients.
Taghvaei M; Sadrehosseini SM; Ardakani JB; Nakhjavani M; Zeinalizadeh M
World Neurosurg; 2018 Sep; 117():e259-e268. PubMed ID: 29902603
[TBL] [Abstract][Full Text] [Related]
37. Final Outcome in Growth Hormone-Secreting Adenomas After Combination of Maximal Tumor Resection and Medical Treatment.
Torres A; Sanmillan JL; Lau R; Gabarros A
World Neurosurg; 2021 Oct; 154():e292-e301. PubMed ID: 34252630
[TBL] [Abstract][Full Text] [Related]
38. Age- and Sex-Specific Differences as Predictors of Surgical Remission Among Patients With Acromegaly.
Park SH; Ku CR; Moon JH; Kim EH; Kim SH; Lee EJ
J Clin Endocrinol Metab; 2018 Mar; 103(3):909-916. PubMed ID: 29272449
[TBL] [Abstract][Full Text] [Related]
39. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.
Kreutzer J; Vance ML; Lopes MB; Laws ER
J Clin Endocrinol Metab; 2001 Sep; 86(9):4072-7. PubMed ID: 11549628
[TBL] [Abstract][Full Text] [Related]
40. Surgical and endocrinological outcomes in the treatment of growth hormone-secreting pituitary adenomas according to the shift of surgical paradigm.
Ku CR; Kim EH; Oh MC; Lee EJ; Kim SH
Neurosurgery; 2012 Dec; 71(2 Suppl Operative):ons192-203; discussion ons203. PubMed ID: 22743357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
